A continuous procedure for the determination of leucine aminopeptidase is described. L-leucinamide is used äs Substrate and the liberated ammonia is determined with the glutamate dehydrogenase reaction. The enzyme is Mn 2 +-activated and 30 / MnCl 2 is necessary for an optimal activity measurement. Influence of buffer type, buffer concentration and pH are reported together with the apparent K m values of leucine aminopeptidase for L-leucinamide and of glutamate dehydrogenase for 2-oxoglutarate. Amastatin, a potent inhibitor, iiihibits the reaction of leucine aminopeptidase completely, whereas it has no inhibitory effect on the reaction with glutamate dehydrogenase. The normal reference interval for leucine aminopeptidase is 12 -65 U/l at 37 °C. The properties of the enzyme are discussed. 
Introduction
formed from L-leucinämide after hydrolysis is deterLeucine aminopeptidase (ot-aminoacyl-peptide mined by paper chromatography (5) or the liberated hydrolase (cytosol); EC 3.4.114) is a zinc-metallö-ammonia is rneasured according to Berthelot (6, 7) or enzyme, which oceurs in tissues and body fluids of by titration (8) . Unti'l now no continuous monitoring all organisms. It was first cryställized from bovine procedure for the determination of leucine aminolens (1) and afterwards purified from hog kidney (2) , peptidase in serum has been described, except for swine kidney (3) and human liver (4) . a method using leucine dehydrogenase (L-leucine: ",, * , · * -i * · NAD+ oxidoreductase (deaminating) EC 1.4.1.9) äs The enzyme is able to hydrolyse ^pepüdes releasing indicator me (9) a single amino acid from the N-terminus of the peptide chain. L-Leucinamide is a suitable Substrate for In the present paper a continuous method is reported, the enzyme. Different methods for the determination in which the ammonia liberated after hydrolysis of Lof the catalytic activity concentration of leucine leucinamide by leucine aminopeptidase is determined aminopeptidase have been described. The leucine according to the following reaction scheme:
L-leucinamide ?^ L-leucine + NH 3 2-oxoglutarate + NH 3 + NADPH + H+ -> L-glutamate + NADP+
The equilibrium of the indicator reaction with glutamate dehydrogenase (L-glutamate: NAD(P)+ oxidoreductase (deaminating) EC 1.4.1.3) lies far to the right, so that changes in absorbance at 340 nm are directly proportional to the concentration of ammonia. The principle of this reaction has been described previously (10 -12) .
The results of our study leading to the development of a continuous procedure for the determination of leucine aminopeptidase are presented. After standing at room temperature for 10 min the rotor was placed in the analyser. The preincubation time at 37 °C was 10 min. After starting the reaction with 63 μΐ of L-leucinamide the decrease in absorbance was read every 30 s from 2 min until 5 min after the beginning of the reaction.
Materials and Methods
In testing the different parameters all other conditions for the reaction rate determinations were held constant.
Blood was taken by venipuncture and promptly centrifuged: the sera were stored at 4 °C and assayed s soon s possible. All catalytic activity concentrations are expressed in U/l.
L-Leucinamide and amastatin were purchased from Sigma, Brunschwig, Amsterdam, The Netherlands, and glutamate dehydrogenase from beef liver (100 mg/10 ml) from Boehringer, Mannheim, FRG. All other Chemicals were reagent grade.
In the statistical analysis we used Studenfs t-test for paired observations.
Results and Discussion
Figure l shows the time dependence of the enzymatic reaction. A linear relationship was observed up to 5 min after starting the reaction with L-leucinamide. Reagent blank and sample blank are also given and these are always subtracted from the determination before the catalytic activity concentrations are calculated.
Figure l shows also the reaction rate s a function of the amount of sample added. The reaction is linear up to 500 U/l and samples with higher activities have to be diluted with saline. " on the leucine aminopeptidase activity could not be determined.
Preincubation of serum with Mn 2 + in the presence of all other reagents except L-leucinamide g ve a catalytic activity concentration that was 10% higher than that obtained by incubation of serum with Mn 2 + alone (129.0 ± 62.8 U/l and 118.1 + 69.3 U/l respectively; n = 17; p < 0.05). Therefore we preincubated the serum with Mn ?+ ions in the total reagent mixture without L-leucinamide in all our determinations.
In figure 2 the effect of various concentrations of Mn 2+ on the determination of leucine aminopeptidase is given. From 25 μπιοΙ/1 to 100 μπιοΐ/ΐ Μη 2 " 1 " ions no further increase of the catalytie activity was observed. We chose a concentration of 30 μηαοΐ/ΐ Mn ?H~i ons in our Standard procedure. Table 2 shows the effect of different buffers on the catalytic activity concentratiori of leucine aminopeptidase. The highest activity concentration was obtained with trietha.nolamine, which was therefore chosen s the assay buffer. In comparison, for example, borate buffer gives only 60% of the activity concentration observed in triethanolamine. Figure 3 shows the dependency of the catalytic activity concentration on the ioriic strength of the buffer triethanolamine. The catalytic activity did not change significantly when the buffer concentration was varied between about 80 and 300 mmol/1. We chose a concentration f 90 mmol/1 triethanolamine.
The pH dependency of the catalytic activity of leucine aminopeptidase is given in figure 4 . The highest activity concentration was obtained at pH 8.2 in a buffer System of 90 mmol/1 triethanolamine. It is obvious that at this pH the combination of both enzymes, leucine aminopeptidase and glutamate dehydrogenase, gives the highest activity concentration. Therefore, no comparison caii be made with the pH Optimum of leucine aminopeptidase from serum (6) or from human liver (4). fractions from pig kidney of 5.21 and 15.7 mimol/1 (13) or from human liver of 7.7 or 10.5 mmol/1 (4). In all our experiments we used a final Substrate concentration of 100 mmol/1 (approximately 15-times the apparent K m value) which resulted in a zero-order rate reaction.
The effect of Variation of the concentration of NADPH is given in figure 6 . It is obvious that no catalytic activity can be measured at concentrations of NADPH less than 50 μιηοΐ/ΐ. We added 300 μπιοΐ/ΐ NADPH to the Standard reaction mixture.
ADP is necessary for stabilisation of the indicator enzyme glutamate dehydrogenase and increases the rate of conversion of NH 3 considerably (11). We added always l .4 mmol/1 ADP to the reaction mixture, which is sufficient for optimal reaction rates ( fig. 7 ).
The influence of increasing amounts of 2-oxoglutarate on the reaction rate is given in figure 8 . The influence of the addition of glutamate dehydrogenase to the reaction mixture is given in figure  9 . Increasing amounts of glutamate dehydrogenase enhance the reaction rate of leucine aminopeptidase. We chose 47 mg/1 glutamate dehydrogenase, which is sufficient for an optimal reaction rate.
The dependence of the measured catalytic activity concentration of leucine aminopeptidase on the relation between sample and total assay volume is seen in figure 10 . There is an increase of the catalytic activity concentration up to a volume fraction of 0.03, and a decrease at higher volume fractions. For practical reasons we chose a volume fraction of sample of 0.037, which is about 2% lower than that required for maximal catalytic activity concentration.
The within-day and between-day variabilites are given in table 3. Generally these results are satisfactory. We carried out all our determinations at 37 °C. The temperature converting factor from 37 °C to 30 °C was 0.614 ± 0.068 for 55 determinations.
Amastatin is a well known inhibitor of leucine aminopeptidase because it binds to cell surfaces and therefore inhibits cell-surface aminopeptidases (15) . Addition of 25 μπιοΐ/ΐ of amastatin to the reaction mixture inhibits the enzyme completely. Amastatin has no inhibitory effect on the glutamate dehydrogenase reaction; (30.2 + 11.3 μιηοΐ/l NH 3 in the absence of amastatin and 33.6 + 7.0 μπιοΙ/1 in its presence; n = 5; p > 0.40).
Leucine aminopeptidase activity concentrations were determined in sera from 144 healthy people. The normal reference interval (mean + 2 S.D.) was 12-65U/lat37°C.
Based on the determination of ammonia described by da Fonseca-Wollheim (10,11), a continuously monitoring procedure has thus been designed for the determination of leucine aminopeptidase. Most of the Parameters of this method are related to the properties of glutamate dehydrogenase, the indicator enzyme of the reaction scheine. But these parameters are also compatible with the measurement of the catalytic activity concentration of leucine aminopeptidase by this method.
It is difficult to distinguish leucine aminopeptidase from amino acid arylamidase (ot-aminoacyl-peptide hydrolase (microsomal) EC 3.4.11.2), although the first enzyme occurs in the cytosol of the cells and the second one is microsomal. These two enzymes show different Substrate specificities. Leucine aminopeptidase hydrolyses leucine-peptides s well s Lleucinamide, while amino acid arylamidase splits preferentially alanine from peptides, amides and 4-nitroanilides; but this Substrate specificity is not absolute. From studies by N H be & Fujii (16) it is obvious that an enzyme preparation of leucine aminopeptidase purified from human liver is able to split L-alanyl--naphthylamide and a purified enzyme preparation of amino acid arylamidase hydrolyses L-leucinamide. Generally it is accepted that Lleucinamide is the preferred Substrate for leucine aminopeptidase originating from tissues or serum.
Plaquet et al. (6) described in normal and pathological human sera two enzymes, which are able to split Lleucinamide. The "alkaline enzyme" has a pH optimum of 9.0 and is activated by Mg 2+ ions, while the second enzyme ("neutral enzyme"), has an optimal activity at pH 7.8 and is inhibited by Mg 2+ ions. The reference value for the "alkaline enzyme" is l .2 U/l at 37 °C. A comparison between the properties of the enzymes described by us and by Plaquet et al. (6) is difficult, because we determined the kinetic properties of leucine aminopeptidase in relation to the properties of the indicator enzyme glutamate dehydrogenase. It seems that the enzymes are distinct, since our enzyme is Mn 2 + activated and the reference value is much higher.
f The clinical value of the leucine aminopeptidase is not exactly kiiowri. The relation between leucine aminopeptidase and amino acid arylamidase is now uiider investigation.
